Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1288, 2001-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis
By Cranney Ann
Drug Safety, Vol. 28, Iss. 8, 2005-01 ,pp. :
Zoledronic acid reduces fracture risk . . .
Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. :
Estrogen/medroxyprogesterone reduces fracture risk
Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. :
Teriparatide: A Review of its Use in Osteoporosis
By Blick Stephanie K.A. Dhillon Sohita Keam Susan J.
Drugs, Vol. 68, Iss. 18, 2008-01 ,pp. :